Succinylacetone
Product Code
TRC-S692060
CAS Number
Product Format
Neat
Molecular Formula
C7 H10 O4
Molecular Weight
158.1519
Product Categories
TRC, Carbohydrate derivatives, Additional pharmaceutical toxicology research materials
Share product
- Product Name: Succinylacetone
- Product Code: TRC-S692060
- CAS Number: 51568-18-4
- Brand: TRC
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
Email download link
{{ errors.first('RequestCoaForm.lotNumber') }}
{{ errors.first('RequestCoaForm.requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('SendDownloadCoaLinkForm.coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors.first('RequestSdsForm.selectedRegion') }}
{{ errors.first('RequestSdsForm.sdsEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
Succinylacetone
CAS Number
51568-18-4
Molecular Formula
C7 H10 O4
Molecular Weight
158.1519
Accurate Mass
158.0579
SMILES
CC(=O)CC(=O)CCC(=O)O
InChI
InChI=1S/C7H10O4/c1-5(8)4-6(9)2-3-7(10)11/h2-4H2,1H3,(H,10,11)
IUPAC
4,6-dioxoheptanoic acid
Product Data
Storage Temperature
-20°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Format
Neat
Product Description
Succinylacetone (SA) is a specific marker for the inherited metabolic disease, hepatorenal tyrosinemia. It was developed a stable-isotope for the determination of SA in dried blood spots (DBS) and liquid urine using a 13C4-SA as internal standard. The method was applied retrospectively and prospectively for the diagnosis of hepatorenal tyrosinemia and for follow-up of patients under treatment.
References: Kvittingen, E., et al.: Inher. Metab. Dis., 14, 554 (1991), Lindstedt, S., et al.: Lancet, 340, 813
{{title}}
Please login or register to add to your favourites
Or continue browsing without access to favourites or pricing
Please log in to view pricing and add to cart
Or continue browsing to see available rounds without pricing information
If you don't yet have an account, please create an account create an account
- Product Code:
{{ isMultiplePacksize(product) ? getSourcePart(product) : product.code }} {{ isMultiplePacksize(product) ? getSourcePart(product) : product.code }}
Controlled product
Login to view full product details
{{ addToCartData.mixPtRmWarning }}
Do you want to proceed?
{{ errors.first('requestQuoteForm.firstName') }}
{{ errors.first('requestQuoteForm.lastName') }}
{{ errors.first('requestQuoteForm.email') }}
{{ errors.first('requestQuoteForm.phoneCountryCode') }}
{{ errors.first('requestQuoteForm.phoneNumber') }}
{{ errors.first('requestQuoteForm.company') }}
{{ errors.first('requestQuoteForm.selectedShippingAddress') }}
{{ errors.first('requestQuoteForm.shippingCompanyName') }}
{{ errors.first('requestQuoteForm.shippingLine1') }}
{{ errors.first('requestQuoteForm.shippingCountry') }}
{{ errors.first('requestQuoteForm.shippingState') }}
{{ errors.first('requestQuoteForm.shippingCity') }}
{{ errors.first('requestQuoteForm.shippingPostCode') }}
{{ errors.first('requestQuoteForm.billingCompanyName') }}
{{ errors.first('requestQuoteForm.billingLine1') }}
{{ errors.first('requestQuoteForm.billingCountry') }}
{{ errors.first('requestQuoteForm.billingState') }}
{{ errors.first('requestQuoteForm.billingCity') }}
{{ errors.first('requestQuoteForm.billingPostCode') }}
{{ errors.first('requestQuoteForm.deliveryCountry') }}
{{ errors.first('requestQuoteForm.packSize') }}
{{ errors.first('requestQuoteForm.quantity') }}